Hospice:
Telehealth F2F, Volunteer, and Many Other Hospice Flexibilities Are Due To Sunset With The PHE
Published on Fri Feb 03, 2023
Plus: Comprehensive assessments will go back to 15-day deadline.
Most hospice flexibilities offered during the COVID-19 public health emergency are going away this year — and some of those departures will take a major toll on providers.
According to a hospice-specific “CMS Flexibilities to Fight COVID-19” sheet updated on Feb. 1, these waiver flexibilities will end with the PHE:
- Telehealth F2F. Recent legislation bought hospices some time when it comes to the face-to-face encounter for recertification via telehealth, but it’s still set to expire “the first day after the 151st day following the end of the PHE,” CMS says — Oct. 9, 2023.
- Volunteers. CMS will again require that hospices use volunteers for at least 5 percent of patient care hours. The agency offers no grace period in the updated sheet.
- Comprehensive assessments. The allowed time frame for updating the comprehensive assessment will go back down to 15 days, compared to 21 days during the PHE.
- Non-core services. CMS will no longer waive the requirement to provide certain non-core services, including physical therapy, occupational therapy, and speechlanguage pathology, when the PHE ends.
- Training and assessment of aides. Like with home health, RNs must again “make an annual onsite supervisory visit [direct observation] for each aide that provides services on behalf of the agency,” although CMS is “postponing completion of these visits,” it says. “All postponed onsite assessments must be completed by these professionals no later than 60 days after the expiration of the PHE.”
- Annual training. CMS will once again require hospices “to annually assess the skills and competence of all individuals furnishing care and provide in-service training and education programs where required.” But it is “postponing the deadline for completing this requirement … until the end of the first full quarter after the declaration of the PHE concludes,” it says.
- QAPI. CMS is ending the waiver allowing agencies to narrow the scope of their Quality Assurance and Performance Improvement program to infection control issues. It will end with the PHE.
- Various enrollment, appeals and Medicare Advantage waivers will end.

Meanwhile, as with home health, CMS will continue to pay about $40 per dose for administering COVID-19 vaccines through the end of 2023, the newly updated sheet says. “Effective January 1 of the year following the year that the PHE ends, CMS will set the payment rate for administering COVID-19 vaccines to align with the payment rate for administering other Part B preventive vaccines.” The sheet also notes that “we’ll continue to pay a total payment of approximately $75 per dose to administer COVID-19 vaccines in the home for certain Medicare patients through the end of the calendar year that the PHE ends,” but makes no mention of continuing the payment after 2023.
Note: See more details in the nine-page sheet at .